Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 3, 2014, Pages 259-266

  Tu, Huakang ^a,b,c   Sun, Liping ^b   Dong, Xiao ^d   Gong, Yuehua ^b   Xu, Qian ^b   Jing, Jingjing ^b   Yuan, Yuan ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Gastric inflammation; Gastrin 17; Helicobacter pylori density; Helicobacter pylori serology; Pepsinogen; Superficial gastritis

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84894164434     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.869352     Document Type: Article

References (33)

1. Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010;10:403-14.
2. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
3. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010;362:1597-604.
4. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
5. Palli D, Decarli A, Cipriani F, Sitas F, Forman D, Amadori D, et al. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiol Biomarkers Prev 1993;2:37-40.
6. Wu MS, Lin JT, Wang JT, Huang SC, Wang CY, Wang TH. Serum levels of pepsinogen I in healthy volunteers and patients with gastric ulcers and gastric carcinoma in Taiwan. J Formos Med Assoc 1993;92:711-16.
7. Lin JT, Wang JT, Wu MS, Huang SC, Wang TH. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics. Hepatogastroenterology 1993;40:600-3.
8. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-6.
9. Wagner S, Haruma K, Gladziwa U, Soudah B, Gebel M, Bleck J, et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroenterol 1994;89:1211-18.
10. Sun LP, Gong YH, Wang L, Yuan Y. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China. World J Gastroenterol 2007;13:6562-7.
11. Tatemichi M, Sasazuki S, Inoue M, Tsugane S. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen. Acta Oncol 2008;47:360-5.
12. Yanaoka K, Oka M, Yoshimura N, Mukoubayashi C, Enomoto S, Iguchi M, et al. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels. Int J Cancer 2008;123:917-26.
13. Tatemichi M, Sasazuki S, Inoue M, Tsugane S. Clinical significance of IgG antibody titer against Helicobacter pylori. Helicobacter 2009;14:231-6.
14. Chen TS, Li FY, Chang FY, Lee SD. Immunoglobulin G antibody against Helicobacter pylori: clinical implications of levels found in serum. Clin Diagn Lab Immunol 2002;9:1044-8.
15. Hsu PI, Lai KH, Tseng HH, Liu YC, Yen MY, Lin CK, et al. Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. J Clin Gastroenterol 1997;25:587-91.
16. Kreuning J, Lindeman J, Biemond I, Lamers CB. Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J Clin Pathol 1994;47:227-31.
17. Plebani M, Basso D, Cassaro M, Brigato L, Scrigner M, Toma A, et al. Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996;91:954-8.
18. Sheu BS, Shiesh SC, Yang HB, Su IJ, Chen CY, Lin XZ. Implications of Helicobacter pylori serological titer for the histological severity of antral gastritis. Endoscopy 1997;29:27-30.
19. Sim JG, Kim CJ, Seo JK. The value of Helicobacter pylori IgG antibody in estimating the severity of gastritis in children. J Korean Med Sci 1995;10:329-33.
20. Yamamoto I, Fukuda Y, Mizuta T, Fukada M, Nishigami T, Shimoyama T. Serum anti-Helicobacter pylori antibodies and gastritis. J Clin Gastroenterol 1995;21:S164-8.
21. Perez-Perez GI, Brown WR, Cover TL, Dunn BE, Cao P, Blaser MJ. Correlation between serological and mucosal inflammatory responses to Helicobacter pylori. Clin Diagn Lab Immunol 1994;1:325-9.
22. Kolho KL, Karttunen R, Heikkila P, Lindahl H, Rautelin H. Gastric inflammation is enhanced in children with CagApositive Helicobacter pylori infection. Pediatr Infect Dis J 1999;18:337-41.
23. Twisk M, Kusters JG, Balk AG, Kuipers EJ, Loffeld RJ. Colonisation density and topographic localisation of Helicobacter pylori do not depend on the cagA status. J Clin Pathol 2001;54:771-3.
24. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996. 20(10):1161-81.
25. Gong YH, Sun LP, Jin SG, Yuan Y. Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7, 241 subjects from China. Eur J Clin Microbiol Infect Dis 2010;29:907-11.
26. Young GO, Stemmet N, Lastovica A, Van Der Merwe EL, Louw JA, Modlin IM, et al. Helicobacter pylori lipopolysaccharide stimulates gastric mucosal pepsinogen secretion. Aliment Pharmacol Ther 1992;6:169-77.
27. Young GO, Brown S, Stemmet N, Lastovica AJ, Marks IN, Modlin IM, et al. The pepsinogen releasing effect of Helicobacter pylori lipopolysaccharide. Helicobacter 2002;7:30-8.
28. Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut 2002;50:13-18.
29. Cave TR, Cave DR. Helicobacter pylori stimulates pepsin secretion from isolated rabbit gastric glands. Scand J Gastroenterol Suppl 1991;181:9-14.
30. Lehmann FS, Schiller N, Cover T, Hatch R, Seensalu R, Kato K, et al. H.pylori stimulates gastrin release from canine antral cells in primary culture. AmJ Physiol 1998;274:G992-6.
31. Di Mario F, Cavallaro LG. Non-invasive tests in gastric diseases. Dig Liver Dis 2008;40:523-30.
32. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
33. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-94.